Orbimed Advisors LLC
124 holdingsFiling period: 2026-06-30Current AUM: $4.79Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | EWTX | Edgewise Therapeutics Inc | 15.52M | $630.5M | $613.4M | 12.82% | -- | 2026-06-30 |
| 2 | ELVN | Enliven Therapeutics Inc | 6.78M | $343.9M | $296.1M | 6.19% | -1,182,906 | 2026-06-30 |
| 3 | LLY | Eli Lilly & Co | 257.9K | $309.3M | $330.6M | 6.91% | +21.1K | 2026-06-30 |
| 4 | MBX | Mbx Biosciences Inc | 3.43M | $189.3M | $181.6M | 3.79% | -209,151 | 2026-06-30 |
| 5 | — | Sinovac Biotech Ltd | 2.72M | $184.5M | $184.5M | 3.85% | -- | 2026-06-30 |
| 6 | — | Astrazeneca PLC | 915.7K | $171.1M | $171.1M | 3.57% | +245.5K | 2026-06-30 |
| 7 | GPCR | Structure Therapeutics Inc | 2.21M | $118.6M | $47.6M | 0.99% | +734.0K | 2026-06-30 |
| 8 | SION | Sionna Therapeutics Inc | 2.56M | $112.4M | $9.9M | 0.21% | -974,825 | 2026-06-30 |
| 9 | CRVS | Corvus Pharmaceuticals Inc | 7.17M | $107.0M | $75.5M | 1.58% | -- | 2026-06-30 |
| 10 | AVBP | Arrivent Biopharma Inc | 3.03M | $105.2M | $46.6M | 0.97% | -- | 2026-06-30 |
| 11 | ABVX | Abivax SA | 746.5K | $99.5M | $64.9M | 1.36% | +280.8K | 2026-06-30 |
| 12 | GH | Guardant Health Inc | 583.7K | $87.6M | $103.9M | 2.17% | +148.5K | 2026-06-30 |
| 13 | ARGX | Argenx SE | 92.9K | $86.2M | $82.0M | 1.71% | -44,020 | 2026-06-30 |
| 14 | MRK | Merck & Co Inc | 663.4K | $85.2M | $94.1M | 1.97% | -- | 2026-06-30 |
| 15 | — | Uniqure NV | 1.81M | $83.3M | $83.3M | 1.74% | -328,663 | 2026-06-30 |
| 16 | PRAX | Praxis Precision Medicines I | 230.1K | $77.0M | $61.6M | 1.29% | +57.6K | 2026-06-30 |
| 17 | EW | Edwards Lifesciences Corp | 834.9K | $75.5M | $75.8M | 1.58% | -395,700 | 2026-06-30 |
| 18 | PRLD | Prelude Therapeutics Inc | 13.72M | $73.2M | $53.3M | 1.11% | +2.82M | 2026-06-30 |
| 19 | DYN | Dyne Therapeutics Inc | 3.24M | $71.9M | $54.8M | 1.15% | +317.8K | 2026-06-30 |
| 20 | NTRA | Natera Inc | 262.0K | $71.1M | $107.6M | 2.25% | -- | 2026-06-30 |
| 21 | UNH | Unitedhealth Group Inc | 171.1K | $71.1M | $70.2M | 1.47% | -- | 2026-06-30 |
| 22 | CGON | CG Oncology Inc | 972.8K | $69.1M | $61.2M | 1.28% | +24.5K | 2026-06-30 |
| 23 | SPRY | Ars Pharmaceuticals Inc | 8.29M | $66.4M | $30.9M | 0.65% | -- | 2026-06-30 |
| 24 | — | Ascendis Pharma A/S | 244.5K | $65.2M | $65.2M | 1.36% | -- | 2026-06-30 |
| 25 | HUM | Humana Inc | 164.1K | $65.2M | $68.1M | 1.42% | -- | 2026-06-30 |
← Scroll →
Page 1 of 5